Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
N-0877 by Eurofarma Laboratorios for Idiopathic (Essential) Hypertension: Likelihood of Approval
N-0877 is under clinical development by Eurofarma Laboratorios and currently in Phase II for Idiopathic (Essential) Hypertension. According to GlobalData,...